Nuvectis Pharma (NASDAQ:NVCT) lost ~45% on Thursday after the oncology-focused biotech announced data from an ongoing ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...

A University of Iowa researcher is using federal funding to develop a new approach to combat ovarian cancer. According to the ...

Kathy Bates has revealed why she decided against reconstruction surgery after her breast cancer diagnosis and mastectomy in ...

University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...

Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...

Followed categories will be added to My News. In a world-first finding, Melbourne researchers investigated a major “blind ...

Kathy Bates explained her decision not to have reconstruction surgery after her 2012 breast cancer diagnosis and double ...

Researchers at the University of California San Diego are hoping to drastically shorten the time between a cancer diagnosis ...

Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, ...